Tae Woo Jung Selected Research

Docosahexaenoic Acids

1/2018	Protectin DX Ameliorates Hepatic Steatosis by Suppression of Endoplasmic Reticulum Stress via AMPK-Induced ORP150 Expression.
1/2018	Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway.
1/2017	Protectin DX ameliorates palmitate- or high-fat diet-induced insulin resistance and inflammation through an AMPK-PPARα-dependent pathway in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tae Woo Jung Research Topics

Disease

43	Inflammation (Inflammations) 04/2024 - 01/2013
37	Insulin Resistance 02/2024 - 05/2006
19	Obesity 04/2024 - 10/2013
15	Non-alcoholic Fatty Liver Disease 02/2024 - 10/2013
7	Type 2 Diabetes Mellitus (MODY) 01/2024 - 05/2007
5	Atherosclerosis 02/2024 - 01/2013
5	Hyperlipidemias (Hyperlipidemia) 05/2023 - 01/2017
4	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2007 - 02/2006
4	Neuroblastoma 02/2007 - 02/2006
4	Parkinson Disease (Parkinson's Disease) 02/2007 - 02/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2023 - 07/2014
2	Dyslipidemias (Dyslipidemia) 04/2024 - 12/2017
2	Wounds and Injuries (Trauma) 11/2023 - 12/2017
2	Metabolic Diseases (Metabolic Disease) 05/2023 - 01/2019
2	Body Weight (Weight, Body) 01/2023 - 05/2006
2	Hypertension (High Blood Pressure) 01/2023 - 12/2017
2	Weight Loss (Weight Reduction) 01/2023 - 01/2018
2	Liver Diseases (Liver Disease) 01/2023 - 01/2018
2	Atrophy 01/2023 - 05/2022
2	Neoplasms (Cancer) 10/2022 - 01/2018
2	Osteoarthritis 01/2022 - 01/2021
2	Rheumatoid Arthritis 01/2022 - 01/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2018 - 02/2007
2	Weight Gain 10/2018 - 01/2017
1	Sarcopenia 04/2024
1	Hyperglycemia 11/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 11/2023
1	Tendinopathy (Tendonitis) 11/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023

Drug/Important Bio-Agent (IBA)

24	PalmitatesIBA 12/2023 - 06/2012
19	Small Interfering RNA (siRNA)IBA 12/2023 - 09/2015
14	LipidsIBA 12/2023 - 11/2015
14	Insulin (Novolin)FDA Link 11/2023 - 01/2012
9	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2007
7	Fatty Acids (Saturated Fatty Acids)IBA 01/2024 - 09/2015
7	AMP-Activated Protein KinasesIBA 12/2020 - 07/2011
6	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2017
6	10,17- dihydroxydocosa- 4,7,11,13,15,19- hexaenoic acidIBA 10/2019 - 01/2017
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 02/2006
5	AdiponectinIBA 12/2017 - 05/2006
4	AcidsIBA 04/2024 - 09/2015
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2018
4	CytokinesIBA 02/2024 - 12/2017
4	MyokinesIBA 01/2023 - 12/2020
4	Sirtuin 1IBA 12/2021 - 06/2012
4	Messenger RNA (mRNA)IBA 01/2018 - 05/2007
4	JNK Mitogen-Activated Protein KinasesIBA 01/2018 - 09/2015
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 10/2014
4	NeurotoxinsIBA 02/2007 - 02/2006
3	AdipokinesIBA 11/2023 - 10/2014
3	ginsenoside M1IBA 11/2023 - 05/2022
3	Kynurenic Acid (Kynurenate)IBA 01/2021 - 01/2019
3	LipopolysaccharidesIBA 01/2020 - 11/2018
3	Adenosine Monophosphate (AMP)IBA 01/2020 - 01/2014
3	Interleukin-6 (Interleukin 6)IBA 11/2019 - 01/2017
3	Selenoprotein PIBA 10/2019 - 01/2013
3	Docosahexaenoic AcidsIBA 01/2018 - 01/2017
3	Chemotactic FactorsIBA 01/2018 - 09/2015
3	LC15-0444IBA 11/2015 - 07/2014
3	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2015 - 07/2014
3	Rosiglitazone (Avandia)FDA Link 05/2007 - 02/2006
2	madecassosideIBA 04/2024 - 11/2023
2	fibroblast growth factor 21IBA 12/2023 - 12/2021
2	Hypoglycemic Agents (Hypoglycemics)IBA 11/2023 - 10/2018
2	GinsenosidesIBA 05/2023 - 07/2011
2	capmatinibIBA 01/2023 - 01/2021
2	Therapeutic UsesIBA 01/2022 - 06/2012
2	valdecoxib (Bextra)FDA Link 01/2022 - 01/2021
2	patchouli alcoholIBA 12/2021 - 01/2021
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 12/2020 - 01/2019
2	Phosphatidylcholines (Phosphatidylcholine)IBA 11/2020 - 01/2018
2	Peptides (Polypeptides)IBA 08/2020 - 01/2020
2	alpha-2-HS-GlycoproteinIBA 10/2019 - 10/2013
2	salicylsalicylic acid (salsalate)IBA 08/2019 - 01/2013
2	Nonesterified Fatty Acids (NEFA)IBA 01/2019 - 05/2007
2	Protein Kinases (Protein Kinase)IBA 01/2019 - 01/2014
2	Triglycerides (Triacylglycerol)IBA 10/2018 - 05/2007
2	Lipoxygenase (Lipoxygenase-1)IBA 01/2018 - 01/2017
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 04/2015 - 07/2014
2	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 02/2007 - 05/2006
2	AcetaldehydeIBA 08/2006 - 02/2006
1	ApolipoproteinsIBA 04/2024
1	3,5-dicaffeoylquinic acidIBA 04/2024
1	Adenosine Triphosphate (ATP)IBA 04/2024
1	Apolipoproteins E (ApoE)IBA 04/2024
1	Interleukin-1 (Interleukin 1)IBA 04/2024
1	Interleukin-27 (Interleukin 27)IBA 02/2024
1	Blood Glucose (Blood Sugar)IBA 11/2023
1	Matrix Metalloproteinases (MMPs)IBA 11/2023
1	Metalloproteases (Metalloproteinases)IBA 11/2023
1	RNA (Ribonucleic Acid)IBA 11/2023
1	TriterpenesIBA 11/2023
1	Cell Adhesion MoleculesIBA 09/2023
1	ginsenoside Rb3IBA 05/2023
1	Buspirone (Buspar)FDA LinkGeneric 01/2023
1	Netrin-1IBA 12/2022
1	RibonucleotidesIBA 12/2022
1	AICA ribonucleotide (ZMP)IBA 12/2022
1	3-methyladenineIBA 12/2022

Therapy/Procedure

2	Therapeutics 12/2021 - 12/2020